Browsing by Author Hung N.A.

Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
2015Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancerHuynh, H ; Ong, R; Zopf, D
2007AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinomaHuynh, H ; Chow, P.K.H ; Soo, K.-C
Jul-2017Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinomaKong, L.R ; Tan, T.Z ; Ong, W.R; Bi, C; Huynh, H ; Lee, S.C ; Chng, W.J ; Eichhorn, P.J.A ; Goh, B.C 
2008Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinomaHuynh, H ; Ngo, V.C; Fargnoli, J; Ayers, M; Khee, C.S; Heng, N.K; Choon, H.T; Hock, S.O; Chung, A ; Chow, P ; Pollock, P; Byron, S; Tran, E
2012Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinomaYuen, J.S.P ; Sim, M.Y; Sim, H.G ; Chong, T.W ; Lau, W.K.O ; Cheng, C.W.S ; Ong, R.W; Huynh, H 
2015Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinomaChua, K.N ; Kong, L.R ; Sim, W.J ; Ng, H.C; Ong, W.R; Thiery, J.P ; Huynh, H ; Goh, B.C